Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Accumulated Depreciation (2020 - 2026)

Biomea Fusion (BMEA) posted Accumulated Depreciation of $601000.0 for Q1 2026, down 40.44% sequentially from $1.0 million in Q4 2025, and down 87.07% YoY from $4.6 million in Q1 2025.

Biomea Fusion (BMEA) Accumulated Depreciation (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Accumulated Depreciation for 7 years, with the latest figure at $601000.0 in Q1 2026.

  • Quarterly Accumulated Depreciation fell 87.07% year-over-year to $601000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $601000.0 (down 87.07% YoY) and the FY2025 annual result came in at $1.0 million, down 75.86% from the prior year.
  • Accumulated Depreciation eased to $601000.0 in Q1 2026 per BMEA's latest filing, from $1.0 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $5.1 million in Q2 2025 and troughed at $391000.0 in Q1 2022.
  • A 5-year average of $2.1 million and a median of $1.6 million in 2023 frame the typical range for Accumulated Depreciation.
  • The sharpest annual moves came in 2022 and 2026: Accumulated Depreciation soared 1855.0% in 2022, then plunged 87.07% in 2026.
  • Over 5 years, Accumulated Depreciation stood at $916000.0 in 2022, then soared by 165.39% to $2.4 million in 2023, then surged by 71.9% to $4.2 million in 2024, then tumbled by 75.86% to $1.0 million in 2025, then tumbled by 40.44% to $601000.0 in 2026.
  • According to Business Quant data, Accumulated Depreciation over the past three periods registered $601000.0, $1.0 million, and $962000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Biomea Fusion 97.69 Mn 97.69 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 601,000.00
Dec 31, 2025 1.01 Mn
Sep 30, 2025 962,000.00
Jun 30, 2025 5.11 Mn
Mar 31, 2025 4.65 Mn
Dec 31, 2024 4.18 Mn
Sep 30, 2024 3.71 Mn
Jun 30, 2024 3.27 Mn
Mar 31, 2024 2.85 Mn
Dec 31, 2023 2.43 Mn
Sep 30, 2023 2.01 Mn
Jun 30, 2023 1.59 Mn
Mar 31, 2023 1.21 Mn
Dec 31, 2022 916,000.00
Sep 30, 2022 733,000.00
Jun 30, 2022 561,000.00
Mar 31, 2022 391,000.00
Dec 31, 2021 257,000.00
Sep 30, 2021 107,000.00
Jun 30, 2021 42,000.00